Details for 2018717108

Up to date per 01.04.2026

Actions

Title / Product Name

MITTEL ZUR ERHÖHUNG DER EXPRESSION DES BCL2-ASSOZIIERTEN AGONISTEN DES ZELLTODS ZUR BEHANDLUNG VON KREBS

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2018717108

EP Publication Number

3600433

E-Number

1388942

Language

PCT Number

GB18050843

Publication Date

05.02.2020 A

05.05.2021 B1

Registration Date

05.05.2021

AT Publication Date

15.05.2021

Application Date

28.03.2018

Registration Number

Priorities

28.03.2017

201704910

14.11.2017

201718806

IPC

A61K 31/485 20060101AFI20201007BHEP

Maximum Duration of Protection

28.03.2038

Owner

LDN Pharma Limited25 Moorgate London, EC2R 6AYGB

Representative

No representatives present

Inventor

DALGLEISH, Angusc/o LDN PHARMA LIMITED Locke Lord (UK) Llp 201 Bishopsgate London Greater London EC1M 3ABGB

LUI, Waic/o LDN PHARMA LIMITED Locke Lord (UK) Llp 201 Bishopsgate London Greater London EC1M 3ABGB